L. Pericleous

437 total citations
18 papers, 328 citations indexed

About

L. Pericleous is a scholar working on Economics and Econometrics, Surgery and Hematology. According to data from OpenAlex, L. Pericleous has authored 18 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 7 papers in Surgery and 4 papers in Hematology. Recurrent topics in L. Pericleous's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). L. Pericleous is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). L. Pericleous collaborates with scholars based in Canada, Denmark and United Kingdom. L. Pericleous's co-authors include Suzanne N. Morin, M. Lebmeier, Jean‐Éric Tarride, Αλεξάνδρα Παπαϊωάννου, Jacques P. Brown, William D. Leslie, Robert Hopkins, Louis Bessette, Natasha Burke and Jonathan D. Adachi and has published in prestigious journals such as European Heart Journal, British Journal of Dermatology and Osteoporosis International.

In The Last Decade

L. Pericleous

18 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Pericleous Canada 10 114 82 68 53 46 18 328
Waleed Hassan Egypt 9 72 0.6× 51 0.6× 10 0.1× 83 1.6× 56 1.2× 63 314
Matthew Walton United Kingdom 10 180 1.6× 12 0.1× 52 0.8× 31 0.6× 31 0.7× 31 379
Katherine D. Wysham United States 12 45 0.4× 59 0.7× 25 0.4× 195 3.7× 45 1.0× 38 384
DL Scott United Kingdom 5 45 0.4× 28 0.3× 17 0.3× 186 3.5× 25 0.5× 8 308
Rosanna Wustrack United States 12 273 2.4× 149 1.8× 15 0.2× 37 0.7× 135 2.9× 38 542
J. Timothy Harrington United States 13 289 2.5× 409 5.0× 50 0.7× 149 2.8× 166 3.6× 27 719
Jun Masuda Japan 10 123 1.1× 27 0.3× 20 0.3× 7 0.1× 104 2.3× 47 376
Mika Tsujimoto Japan 10 108 0.9× 293 3.6× 14 0.2× 107 2.0× 227 4.9× 16 471
Michael Plant United Kingdom 16 100 0.9× 63 0.8× 23 0.3× 504 9.5× 34 0.7× 27 797
Taru Hallinen Finland 12 59 0.5× 7 0.1× 102 1.5× 87 1.6× 17 0.4× 29 374

Countries citing papers authored by L. Pericleous

Since Specialization
Citations

This map shows the geographic impact of L. Pericleous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pericleous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pericleous more than expected).

Fields of papers citing papers by L. Pericleous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pericleous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pericleous. The network helps show where L. Pericleous may publish in the future.

Co-authorship network of co-authors of L. Pericleous

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pericleous. A scholar is included among the top collaborators of L. Pericleous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pericleous. L. Pericleous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Erim, Daniel, Yi Qian, Devon J. Boyne, et al.. (2022). Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada. Oncology and Therapy. 10(1). 195–210. 8 indexed citations
2.
3.
Oh, Paul, et al.. (2020). PCV32 ECONOMIC BURDEN OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SPECIFIC EVENTS IN ONTARIO, CANADA. Value in Health. 23. S96–S96. 2 indexed citations
4.
Wein, Theodore, et al.. (2020). New View on the Canadian Burden of Stroke: Productivity Loss in Adults Who Return to Work. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(3). 421–424. 2 indexed citations
5.
6.
7.
8.
Chen, Guanmin, Megan S. Farris, Stephen Colgan, et al.. (2019). Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta. Canadian Journal of Cardiology. 35(7). 884–891. 21 indexed citations
9.
Pericleous, L., et al.. (2019). The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all. Journal of Medical Economics. 22(5). 478–487. 2 indexed citations
10.
Hopkins, Robert, Natasha Burke, William D. Leslie, et al.. (2016). The current economic burden of illness of osteoporosis in Canada. Osteoporosis International. 27(10). 3023–3032. 98 indexed citations
11.
Tarride, Jean‐Éric, Natasha Burke, William D. Leslie, et al.. (2016). Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatrics. 16(1). 84–84. 51 indexed citations
12.
Hatswell, Anthony J., Becky Pennington, L. Pericleous, et al.. (2014). Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health and Quality of Life Outcomes. 12(1). 140–140. 39 indexed citations
13.
DiBenedetti, Dana, Theresa Coles, Tarang Sharma, L. Pericleous, & Roshni Kulkarni. (2014). Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web‐based study in the United States and Canada. Haemophilia. 20(4). e296–303. 12 indexed citations
14.
Pericleous, L., et al.. (2014). The burden and management of FXIII deficiency. Haemophilia. 20(6). 733–740. 14 indexed citations
15.
Hutchings, Adam, et al.. (2013). Payer Assessment and Reimbursement Policy for Rare Diseases: A Review of the Literature. Value in Health. 16(7). A391–A391. 1 indexed citations
16.
Lorigan, Paul, Maria Marples, Mark Harries, et al.. (2013). Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. British Journal of Dermatology. 170(1). 87–95. 10 indexed citations
17.
Guyot, Patricia, Peter C. Taylor, Robin Christensen, et al.. (2012). Indirect Treatment Comparison of Abatacept with Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom. The Journal of Rheumatology. 39(6). 1198–1206. 18 indexed citations
18.
Guyot, Patricia, Peter C. Taylor, Robin Christensen, et al.. (2011). Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis. Arthritis Research & Therapy. 13(6). R204–R204. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waleed Hassan Breakdown of academic impact, for papers by Matthew Walton Breakdown of academic impact, for papers by Katherine D. Wysham Breakdown of academic impact, for papers by DL Scott Breakdown of academic impact, for papers by Rosanna Wustrack Breakdown of academic impact, for papers by J. Timothy Harrington Breakdown of academic impact, for papers by Jun Masuda Breakdown of academic impact, for papers by Mika Tsujimoto Breakdown of academic impact, for papers by Michael Plant Breakdown of academic impact, for papers by Taru Hallinen
Rankless by CCL
2026